FindTrial
Sign In

to study the medication adherence of anti-HIV medicines in people living with HIV/AIDS

To evaluate the medication adherence and adverse effects of HAART in people living with HIV/AIDS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/051142
Enrollment
200
Registered
2023-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

None listed

Sponsors

GGS Medical college and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients �18 years of age, irrespective of gender. Patients on HAART regimen for � 3 months

Exclusion criteria

Exclusion criteria: Hepatitis B and Hepatitis C co- infections Patients withunderlying psychiatric illness Critically ill patients/hospitalized patients/end stage disease patients (cardiac/renal/hepatic failure/malignancies)

Design outcomes

Primary

MeasureTime frame
Assess the medication adherence of HAART in people living with HIV/AIDS by using MARS questionnaireTimepoint: 0 week and 24 weeks—

Secondary

MeasureTime frame
assess the adverse events of HAART in people living with HIV/AIDS by using ADR form and by blood investigations viz LFT RFT and otherTimepoint: 0 week and 24 weeks—

Countries

India

Contacts

Public ContactShaminder Kaur

Guru Gobind Singh Medical College and Hospital

anurajkumar76@gmail.com9814286248

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026